KDx Diagnostics
Shahram Shawn Gholami is a highly experienced surgeon and healthcare professional who currently holds various key positions in several companies including UASV, El Camino Health, GM Ventures, Urological Surgeons of Northern California, Resurge Therapeutics, KDx Diagnostics Inc., LUGPA, Arthrex, Stryker, and Good Samaritan Hospital. Educated at Cornell University, Boston University School of Medicine, and the University of California, San Francisco, Shahram specializes in surgical oncology, laparoscopic, and robotic surgical oncology.
This person is not in any offices
KDx Diagnostics
KDx Diagnostics is the developer of the Uro17™ bladder cancer test, which should be the most sensitive and specific urine test for bladder cancer detection when launched.